Yakov Kogan - Net Worth and Insider Trading
Yakov Kogan Net Worth
The estimated net worth of Yakov Kogan is at least $140,179 dollars as of 2024-05-25. Yakov Kogan is the COO, Secretary of Cleveland BioLabs Inc and owns about 32,225 shares of Cleveland BioLabs Inc (CBLI) stock worth over $140,179. Details can be seen in Yakov Kogan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Yakov Kogan has not made any transactions after 2011-08-19 and currently still holds the listed stock(s).
Transaction Summary of Yakov Kogan
Yakov Kogan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yakov Kogan owns 2 companies in total, including Cleveland BioLabs Inc (CBLI) , and Statera BioPharma Inc (STAB) .
Click here to see the complete history of Yakov Kogan’s form 4 insider trades.
Insider Ownership Summary of Yakov Kogan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CBLI | Cleveland BioLabs Inc | 2015-04-22 | director & Chief Executive Officer |
| STAB | Statera BioPharma Inc | 2006-07-20 | director & Executive Vice President |
Yakov Kogan Latest Holdings Summary
Yakov Kogan currently owns a total of 1 stock. Yakov Kogan owns 32,225 shares of Cleveland BioLabs Inc (CBLI) as of August 19, 2011, with a value of $140,179.
Latest Holdings of Yakov Kogan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CBLI | Cleveland BioLabs Inc | 2011-08-19 | 32,225 | 4.35 | 140,179 |
Holding Weightings of Yakov Kogan
Yakov Kogan Form 4 Trading Tracker
According to the SEC Form 4 filings, Yakov Kogan has made a total of 0 transactions in Cleveland BioLabs Inc (CBLI) over the past 5 years. The most-recent trade in Cleveland BioLabs Inc is the acquisition of 65 shares on August 19, 2011, which cost Yakov Kogan around $2,977.
Insider Trading History of Yakov Kogan
- 1
Yakov Kogan Trading Performance
GuruFocus tracks the stock performance after each of Yakov Kogan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yakov Kogan is 20.7%. GuruFocus also compares Yakov Kogan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yakov Kogan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yakov Kogan's insider trading performs compared to the benchmark.
Performance of Yakov Kogan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 34.8 | | | | | |
| Relative Return to S&P 500(%) | 27.63 | | | | | |
Yakov Kogan Ownership Network
Yakov Kogan Owned Company Details
What does Cleveland BioLabs Inc do?
Who are the key executives at Cleveland BioLabs Inc?
Yakov Kogan is the director & Chief Executive Officer of Cleveland BioLabs Inc. Other key executives at Cleveland BioLabs Inc include Vice President of Finance Christopher Zosh , Principal Financial Officer John Edward Szydlo , and President & CMO Langdon L Miller .
Cleveland BioLabs Inc (CBLI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cleveland BioLabs Inc (CBLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cleveland BioLabs Inc (CBLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cleveland BioLabs Inc (CBLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cleveland BioLabs Inc Insider Transactions
Yakov Kogan Mailing Address
Above is the net worth, insider trading, and ownership report for Yakov Kogan. You might contact Yakov Kogan via mailing address: 11000 Cedar Ave., Suite 280, Cleveland Oh 44106.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
